ÂÜÀòÂÒÂ×

Hamed Piri-Moghadam is an Associate Principal Scientist at Merck, specializing in Discovery Analytical Research. With over 12 years of experience in chromatography and a strong background in mass spectrometry, Hamed has contributed to various projects in biomarker discovery and method development across multiple institutions, including Takeda and Ann & Robert H. Lurie Children's Hospital of Chicago. They obtained a PhD in Analytical Chemistry from Sharif University of Technology and held postdoctoral positions at the University of Waterloo, Memorial University of Newfoundland, and the University of Alberta. Hamed's expertise encompasses a wide range of techniques, including solid-phase extraction and high-throughput screening methodologies.